The landscape of obesity treatment is changing rapidly. With more FDA-approved GLP-1 medications becoming available, people affected by obesity now have treatment options that were not accessible in the past. As costs decline and insurance coverage slowly expands, now is an important time to review your options and understand potential benefits. The Obesity Action Coalition
Read Article